Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Max Cyte Appoints Ali Soleymannezhad As Chief Commercial Officer

PUBLIC · MXCTOct 10, 2024over 1 year ago

Position

Chief Commercial Officer

Company

SeQure Dx

Ali Soleymannezhad
RockvilleBiotechnology

Description

MaxCyte, Inc. announced the appointment of Ali Soleymannezhad as Chief Commercial Officer, effective as of September 11, 2024.

Company Information

Company

SeQure Dx

Location

22 FIRSTFIELD ROAD

Rockville, Maryland, United States

About

Founded in 2008, the firm has over $450 million in capital under management with a mission to bring bench-to-bedside innovations to market to solve unmet medical needs for the benefit of patients worldwide. SeQure Dx was founded on exclusive licensure of GUIDE-seq, ONE-seq and related assay technologies for detection of off-target gene-editing events. ”Nancy Hong, PhD, managing director at RiverVest Venture Partners said: “RiverVest is thrilled to participate in this transformative technology arena. SeQure Dx is uniquely positioned to aid gene-editing innovators in providing safe patient access to novel treatments, and we are pleased to support SeQure Dx through this accelerated growth period.”Carl Berke, PhD, a partner at Mass General Brigham Ventures, said, “Mass General Brigham Ventures has the privilege of supporting the development of this important contribution to the future of cell and gene therapy through the dedicated efforts of SeQure Dx.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for SeQure Dx's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.